методические рекомендации на тему эпидемиологические исследования паркинсонизма,
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                PLOS ONE | https://doi.org/10.1371/journal.pone.0185526 September 28, 2017
Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Lisboa, Portugal
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                orientaciones provisionales, 23 de diciembre de 2020
En  este  documento  se  resumen  las  recomendaciones  de  la  OMS  para  utilizar  de  forma  racional  los  equipos  de  protección personal  (EPP)  tanto  en  los  centros  sanitarioscomo en los domicilios, así como durante la manipulación... de mercancías. Además, se analizan las interrupciones actuales que sufre la cadena mundial de suministro y se tratan aspectos que  cabe  tener  en  cuenta  para  tomar  decisiones  durante  periodos de escasez grave de estos equipos.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2, ...including genomic sequencing, or are involved in making decisions on establishing or scaling up capability and capacity to detect and characterize circulating SARS-CoV-2 variants.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                manuel de mise en oeuvre de l’OMS
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                October 2009 | Volume 6 | Issue 10 | e1000162
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                International Health and Human Rights (2018) 18:18
Disability awareness, Community, Attitudes, Experts-by-experience
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                PLoS ONE 9(6): e99880. doi:10.1371/journal.pone.0099880
Published June 17, 2014
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health... workers based on the transmission scenario, setting, and activity in the context of COVID-19 (Annex 1), and updated considerations for the decontamination or reprocessing of PPE (Annex 2). This guidance is intended for public health authorities, organizations, and focal persons involved in decisions regarding PPE distribution, management, and use by health workers.
Available in Arabic, French, English, Spanish and Russian
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...l adaptation. A first Roadmap on raised blood pressure was published in 2015. Since then, advances in hypertension have included the publication of new clinical guidelines (AHA/ACC; ESC; ESH/ISH); the launch of the WHO Global HEARTS Initiative in 2016 and the associated Resolve to Save Lives (RTSL) initiative in 2017; the inclusion of single-pill combinations on the WHO Essential
Medicines’ list as well as various advances in technology, in particular telemedicine and mobile health. Given the substantial benefit accrued from effective interventions in the management of hypertension and their potential for scalability in low and middle-income countries (LMICs), the WHF has now revisited and updated the ‘Roadmap for raised BP’ as ‘Roadmap for hypertension’
by incorporating new developments in science and policy. Even though cost-effective lifestyle and medical interventions to prevent and manage hypertension exist, uptake is still low, particularly in resource-poor areas. This Roadmap examined the roadblocks pertaining to both the demand side (demographic and socio-economic factors, knowledge and beliefs, social relations, norms, and
traditions) and the supply side (health systems resources and processes) along the patient pathway to propose a range of possible solutions to overcoming them. Those include the development of population-wide prevention and control programmes; the implementation of opportunistic screening and of out-of-office blood pressure measurements; the strengthening of primary care and a greater focus on task sharing and team-based care; the delivery of people-centred care and stronger patient and carer education; and the facilitation of adherence to treatment. All of the above are dependent upon the availability and effective distribution of good quality, evidencebased, inexpensive BP-lowering agents.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Временное руководство23 декабря 2020 г.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Available in English, French and Spanish
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...es on the epidemiology and management of cardiac arrhythmias in LMICs. This review will highlight the unique challenges and opportunities that these countries face when managing cardiac arrhythmias.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                PLOS ONE | DOI:10.1371/journal.pone.0142290 November 9, 2015; 1 / 16
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...ostics are highly accurate, cost-effective, reduce the time to treatment initiation, and impact patient-important outcomes.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                23 décembre 2020 Ce document résume les recommandations de l'OMS concernant l'utilisation rationnelle des équipements de protection individuelle (EPI) dans les établissements de soins de santé et les stratégies temporaires en cas de pénurie aiguë d'approvisionnement. Ce document contient ég...alement 2 sections en annexe qui décrivent les recommandations actualisées d'utilisation des EPI pour les travailleurs de la santé en fonction du scénario de transmission, du milieu et de l'activité dans le contexte de COVID-19 (annexe 1), et des considérations actualisées pour la décontamination ou le retraitement des EPI (annexe 2). Ce guide est destiné aux autorités de santé publique, aux organisations et aux personnes de référence impliquées dans les décisions concernant la distribution, la gestion et l'utilisation des EPI par les travailleurs de la santé.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                manual de aplicación de la OMS
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Heart failure (HF) is a global public health concern with disproportionate socioeconomic, morbidity and mortality burden on low- and middle-income countries (LMICs). This review summarises contemporary data on the demographic and clinical characteristics, aetiologies, treatment, economic burden and ...outcomes of HF in LMICs. Patients with HF in LMICs are younger than those from high-income countries (HICs) and present at advanced stages of the disease. Hypertension, ischaemic heart disease (IHD), cardiomyopathy (CMO), and rheumatic heart disease (RHD) are the leading causes of HF in LMICs. The contribution of infectious diseases to HF remains prominent in many LMICs. Most health facilities in LMICs lack adequate diagnostic tools for HF, and the use of evidence-based medical and device therapies is suboptimal. Further, HF in LMICs is associated with prolonged hospital stay and high in-hospital and one-year mortality. Finally, HF has profound economic impact on individual patients who, mostly, have no health insurance, and on societies where patients are young, comprising those who have the greatest potential to contribute to economic productivity.
                                                                    more